KLRS
Kalaris Therapeutics, Inc.
3.10$
-1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +233.3% | +0.0% | +0.0% | – | |
| – | – | +0.0% | +938.7% | -18.6% | +6.9% | +33.6% | +58.0% | +8.0% | -47.8% | +74.2% | +11.0% | – | |
| – | – | – | – | – | -189.6% | – | -175.9% | – | – | -139.6% | – | – | |
| – | – | – | – | – | – | – | – | – | -90.7% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -436.0% | – | – | |
| – | – | – | – | -100.0% | – | -24.8% | -100.0% | – | – | – | – | – | |
| – | – | -4.1% | -24.3% | -100.0% | +757,600.0% | +1,315.7% | -97.8% | -100.0% | – | -99.9% | -86.5% | – | |
| – | – | -24.4% | -50.8% | +1,097.1% | -102.3% | – | -112.6% | – | – | -214.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.